DID YOU KNOW? EDUCATION FEATURES HEAT OF THE MOMENT TRENDING ALL YOU NEED TO KNOW ABOUT HANTAVIRUS By Admin Posted on March 24, 2020 14 min read 0 0 Share on Facebook Share on Twitter Share on Google+ Share on Pinterest Share on Linkedin CAUSES. CLINICAL FEATURES. DIAGNOSIS. PREVENTION. CURE? Hantaviruses are a family of viruses spread mainly by rodents and can cause varied disease syndromes in people worldwide. Infection with any hantavirus can produce hantavirus disease in people. Hantaviruses in the Americas are known as “New World” hantaviruses and may cause hantavirus pulmonary syndrome (HPS). Other hantaviruses, known as “Old World” hantaviruses, are found mostly in Europe and Asia and may cause hemorrhagic fever with renal syndrome (HFRS). Each hantavirus serotype has a specific rodent host species and is spread to people via aerosolized virus that is shed in urine, feces, and saliva, and less frequently by a bite from an infected host. Due to the small number of HPS cases, the “incubation time” is not positively known. However, on the basis of limited information, it appears that symptoms may develop between 1 and 8 weeks after exposure to fresh urine, droppings, or saliva of infected rodents. Three main clinical syndromes can be distinguished after hantavirus infection: haemorrhagic fever with renal syndrome (HFRS), mainly caused by Seoul, Puumala and Dobrava viruses; nephropathia epidemica, a mild form of HFRS caused by Puumala virus; and hantavirus cardiopulmonary syndrome, which may be caused by Andes virus, Sin Nombre virus, and several others. There is no curative treatment for hantavirus infection, and eliminating or minimising contact with rodents is the best way to prevent infection Early Symptoms Early symptoms include fatigue, fever and muscle aches, especially in the large muscle groups—thighs, hips, back, and sometimes shoulders. These symptoms are universal. There may also be headaches, dizziness, chills, and abdominal problems, such as nausea, vomiting, diarrhea, and abdominal pain. About half of all HPS patients experience these symptoms. Late Symptoms Four to 10 days after the initial phase of illness, the late symptoms of HPS appear. These include coughing and shortness of breath, with the sensation of, as one survivor put it, a “…tight band around my chest and a pillow over my face” as the lungs fill with fluid. Is the Disease Fatal? Yes. HPS can be fatal. It has a mortality rate of 38%. NAME AND NATURE OF INFECTING ORGANISM The term hantavirus refers to a genus covering several tens of species or genotypes globally; six so far in Europe, differing in their virulence to humans. Each hantavirus has a specific rodent host species, or a group of closely related host species. Hantaviruses are expanding in Europe: they are found in new areas and the incidence has increased in several established endemic regions. The most common European hantavirus disease is caused by Puumala hantavirus, carried by the bank vole (Myodes glareolus). The virus is widespread across most of the continent, except for the UK, the Mediterranean coastal regions and the northernmost areas. Dobrava hantavirus, carried by the yellow-necked mouse (Apodemus flavicollis), is found only in south-east Europe, as far as the Czech Republic and southernmost Germany in the north, though the carrier species has a much wider distribution in Europe to the west and north. Other hantaviruses in Europe, but with less public health importance, include Saaremaa hantavirus, carried by the striped field mouse (Apodemus agrarius) and found in eastern and central Europe and the Baltic states; Seoul hantavirus, carried by rats (Rattus norvegicus, R. rattus); Tula hantavirus, carried by Microtus voles; and Seewis hantavirus, common in shrews (Sorex araneus), and only recently found in Europe. Clinical illness results in haemorrhagic fever with renal syndrome (also called “nephropatia epidemica”) and causes less than 0.5% mortality. CLINICAL FEATURES Overall, three syndromes are caused by hantaviruses: (1) Haemorrhagic fever with renal syndrome (HFRS), mainly in Europe and Asia; (2) Nephropathia epidemica (NE), a mild form of HFRS, caused by Puumala hantavirus, and occurring in Europe; (3) Hantavirus cardiopulmonary syndrome (HCPS), in the Americas. The clinical features in patients with hantavirus disease are quite variable, from asymptomatic to severe. The incubation period is relatively long, mostly 2–3 weeks, but may be up to six weeks. In endemic areas hantavirus infection should be suspected if acute fever is accompanied by thrombocytopenia, headache, often very severe, and abdominal and back pains without clear respiratory tract symptoms. The case fatality rate due to Puumala virus infection ranges between less than 0.1 and 0.4%. Recovery usually begins during the second week of illness and is accompanied by improvement of urinary output resulting in polyuria. Full recovery may, however, take weeks. Longer-lasting complications are rare, and include glomerulonephritis, Guillain-Barré syndrome, hypopituitarism, and hypertension. The clinical picture of Dobrava virus infections is very similar, but the symptoms are more severe, with a higher case fatality rate. TRANSMISSION Reservoir Rodents like the bank voles and the yellow-necked mouse are the reservoir for hantaviruses. In the northern part of Europe, human epidemics occur during the cyclic population peaks of the host species. In temperate Europe, on the other hand, human epidemics are related to the (irregular) occurrence of mast years, i.e. years with heavy seed crops of oak and beech leading to abundance of seed-eating rodent species including A. flavicollis. Carrier rodents often invade the human settlements in the autumn thus increasing risk. During rodent peak years, a high proportion of rodents can be seropositive. After being infected, bank voles start to shed the virus after 5–6 days, and the excretion continues for about two months. Transmission mode The rodents excrete hantaviruses in the urine, faeces and saliva, and human infection takes place mostly via inhalation of aerosolised virus-contaminated rodent excreta. Therefore rodent-infested dusty places are risk sites. No human–to-human transmission is known for European hantaviruses. No arthropod vectors are known for hantaviruses. Risk groups Occupations such as forestry workers and farmers have an increased risk of exposure PREVENTION Eliminate or minimize contact with rodents in your home, workplace, or campsite. If rodents don’t find that where you are is a good place for them to be, then you’re less likely to come into contact with them. Seal up holes and gaps in your home or garage. Place traps in and around your home to decrease rodent infestation. Clean up any easy-to-get food. Recent research results show that many people who became ill with HPS developed the disease after having been in frequent contact with rodents and/or their droppings around a home or a workplace. On the other hand, many people who became ill reported that they had not seen rodents or rodent droppings at all. Therefore, if you live in an area where the carrier rodents are known to live, try to keep your home, vacation place, workplace, or campsite clean. DIAGNOSIS The diagnosis of hantavirus disease mainly relies on the detection of antibodies, through immuno-fluorescent assays (IFA) or Enzyme Immuno Assays (EIA). In the acute phase of the hantavirus infection, antibodies are not specific. Low avidity of IgG antibodies and granular fluorescence in IFA of acute sera can be used to separate old from new infection. In recent years, immuno-chromatographic IgM assays as a point-of-care test with an optical reader, has been developed. RT-PCR from patient blood is coming into use. MANAGEMENT AND TREATMENT The treatment of hantavirus disease is mainly symptomatic. Maintaining the fluid balance, while avoiding over-hydration in a potentially oliguric patient is of critical importance. In case of renal insufficiency, dialysis may be required. Because European hantaviruses do not spread from human to human, no isolation is needed. Ribavirin is the only drug used in severe hantavirus infections in Europe. There is currently no vaccine available in Europe. KEY AREAS OF UNCERTAINTY Hantavirus diseases are under-diagnosed in many regions in Europe; locally adapted guidelines to raise awareness are needed. The respective role of different rodent species in transmitting RBD needs to be further assessed. Rodent vector control strategies need to be further developed and fine-tuned.